Philomène Lavis

409 total citations
9 papers, 253 citations indexed

About

Philomène Lavis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Infectious Diseases. According to data from OpenAlex, Philomène Lavis has authored 9 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Philomène Lavis's work include Peptidase Inhibition and Analysis (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and COVID-19 Clinical Research Studies (2 papers). Philomène Lavis is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and COVID-19 Clinical Research Studies (2 papers). Philomène Lavis collaborates with scholars based in Belgium and Netherlands. Philomène Lavis's co-authors include Isabelle Salmon, Myriam Remmelink, Christine Decaestecker, Lorenzo Peluso, Jean‐Louis Vincent, Fabio Silvio Taccone, Nicky D’Haene, Laetitia Lebrun, Marie-Lucie Racu and Calliope Maris and has published in prestigious journals such as Frontiers in Immunology, Critical Care and Cells.

In The Last Decade

Philomène Lavis

8 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philomène Lavis Belgium	6	168	102	51	38	31	9	253
Vika Damay Indonesia	6	215 1.3×	137 1.3×	48 0.9×	16 0.4×	37 1.2×	7	281
Meng Cao United States	4	229 1.4×	205 2.0×	80 1.6×	19 0.5×	41 1.3×	7	321
Hanna Jerndal Sweden	2	137 0.8×	93 0.9×	68 1.3×	20 0.5×	22 0.7×	4	230
Maira Hassan Pakistan	7	149 0.9×	78 0.8×	63 1.2×	34 0.9×	47 1.5×	21	219
André Santa Cruz Portugal	5	168 1.0×	93 0.9×	20 0.4×	26 0.7×	28 0.9×	11	306
Alicia Ang Singapore	4	167 1.0×	172 1.7×	43 0.8×	31 0.8×	52 1.7×	5	250
Bo Ram Koh South Korea	3	186 1.1×	108 1.1×	40 0.8×	32 0.8×	24 0.8×	4	259
Domenica Zaino Italy	5	148 0.9×	109 1.1×	33 0.6×	25 0.7×	36 1.2×	9	217
Muxin Zhu China	6	217 1.3×	142 1.4×	68 1.3×	13 0.3×	18 0.6×	8	261

Countries citing papers authored by Philomène Lavis

Since Specialization

Citations

This map shows the geographic impact of Philomène Lavis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philomène Lavis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philomène Lavis more than expected).

Fields of papers citing papers by Philomène Lavis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philomène Lavis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philomène Lavis. The network helps show where Philomène Lavis may publish in the future.

Co-authorship network of co-authors of Philomène Lavis

This figure shows the co-authorship network connecting the top 25 collaborators of Philomène Lavis. A scholar is included among the top collaborators of Philomène Lavis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philomène Lavis. Philomène Lavis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Lavis, Philomène, et al.. (2024). The fibroblast activation protein alpha as a biomarker of pulmonary fibrosis. Frontiers in Medicine. 11. 1393778–1393778. 3 indexed citations

Lavis, Philomène, et al.. (2024). Chemerin: A Novel Player in Pulmonary Fibrosis. A5189–A5189. 1 indexed citations

Lavis, Philomène, Benjamin Bondue, & Alessandra K. Cardozo. (2024). The Dual Role of Chemerin in Lung Diseases. Cells. 13(2). 171–171. 5 indexed citations

Lavis, Philomène, Gilles Doumont, Gaëtan Van Simaeys, et al.. (2023). Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis. Respiratory Research. 24(1). 254–254. 9 indexed citations

Lavis, Philomène, Gilles Doumont, Gaëtan Van Simaeys, et al.. (2023). Fibroblast Activation Protein Inhibitor, a Promising Radiotracer in Fibrogenesis. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). A4704–A4704.

Muylem, Alain Van, Véronique Corbière, Carmen Orte Cano, et al.. (2022). SP-D and CC-16 Pneumoproteins' Kinetics and Their Predictive Role During SARS-CoV-2 Infection. Frontiers in Medicine. 8. 761299–761299. 15 indexed citations

Lavis, Philomène, Carmen Orte Cano, Véronique Corbière, et al.. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in Immunology. 13. 941663–941663. 14 indexed citations

Lavis, Philomène, et al.. (2021). Comparison of antemortem clinical diagnosis and post-mortem findings in intensive care unit patients. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(2). 385–392. 15 indexed citations

Remmelink, Myriam, Ricardo De Mendonça, Nicky D’Haene, et al.. (2020). Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Critical Care. 24(1). 495–495. 191 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact